Press Releases

June 25 2014

Transparent Communication Important for Patients and Physicians

May 29 2014

Delaware Governor Markell signed legislation designed to create a pathway for the substitution...

May 16 2014

BIO and Delaware Bio call upon Governor Markell to sign critical legislation to create a...

April 10 2014

BIO and Delaware Bio commend the Delaware State Senate for unanimously passing...

April 9 2014

The House Subcommittee on Capital Markets and Government Sponsored Enterprises held a hearing...

March 25 2014

The Biotechnology Industry Organization (BIO) and the Indiana Health Industry Forum (IHIF)...

February 26 2014

Transparent communication important for Patients and Physicians

January 22 2014

BIO and WBBA commend the Washington State House and Senate for continuing to advance...

November 18 2013

San Diego Interim Mayor Todd Gloria to discuss regional growth and economic impact of biotech...

November 13 2013

The Pennsylvania Senate Public Health and Welfare Committee approved Senate Bill 405, which...

October 22 2013

Pending Legislation will Protect Indiana Citizens Utilizing Biologic Medications
to...

September 11 2013

Pending Legislation will Protect Pennsylvanians Utilizing Biologic Medications to Manage...

June 7 2013

Oregon Governor John Kitzhaber signed legislation on Thursday, June 6 designed to address the...

June 5 2013

House Bill 365, signed by Governor Rick Scott, contains four of BIO’s five principles on...

June 3 2013

Florida's repeal of the state Renewable Fuel Standard could chill investment, innovation...

April 23 2013

The Biotechnology Industry Organization (BIO) released its “Bioscience Economic...

April 11 2013

BIO stands ready to work with the Administration to develop policies that help spur innovation...

April 3 2013

The Biotechnology Industry Organization (BIO) and ...

March 21 2013

In statehouses around the country, lawmakers are beginning to address the complexities of...

January 23 2013

Ken Lisaius has been named Vice President of Communications at BIO.

July 27 2012

The measure forces certain companies to pay for disposal.

June 19 2012

Fifth biennial report by Battelle outlines 6.4% job growth in sector from 2001 to 2010, while...

June 14 2012

Support Of Industry Underscores Pro-Business Commitment

March 2 2012

The Biotechnology Industry Organization (BIO) announced today that it has integrated its...

January 17 2012

Bittenbender will spearhead BIO’s engagement in and support of state-level legislative...

November 16 2011

"The most important return on investment from this initiative would be the creation of...

October 26 2011

 BIO Commends Governor Nixon and Missouri Legislature for Commitment to Industry

September 28 2011

The Mississippi Biotechnology Association has joined the Council of State Bioscience...

June 8 2011

BIO announces that Governor Pat Quinn has been selected as the 2011 BIO Governor of the Year...

May 4 2011

The Biotechnology Industry Organization (BIO) announced today its selection of Congressman...

March 3 2011

The Virginia Refundable Research and Development Tax Credit, recently passed by the Virginia...

February 9 2011

BIO and several of its member companies will offer input on progress and potential adjustments...

October 14 2014
The Biotechnology Industry Organization (BIO) welcomes the opportunity to provide comments to Public Consultation #8 published by the Brazilian Ministry of Health on August 14, 2014 which proposes a new regulation defining the guidelines and criteria for the submission, formation, monitoring and evaluation of PDP (Public-Private Productive Development Partnerships) projects.
January 31 2014
Dear Ms. Badrov:   The Biotechnology Industry Organization (BIO) and the Illinois Biotechnology Industry Organization (iBIO) appreciate this opportunity to comment on the Illinois Department of Healthcare and Family Services (the “Department”) proposed rule to amend 89 Ill. Adm. Code 140 regarding the 340B Drug Discount Program (the “Proposed Rule”).    BIO is the largest trade association to serve and represent the biotechnology industry in the United States and around the globe.  Indeed, BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations.   BIO members are involved in the research and development of healthcare, agricultural, industrial, and environmental biotechnology products.  In Illinois BIO works in collaboration with iBIO, whose membership includes strong representation from the bio-pharmaceutical sector.  This sector accounts for a large portion of the $98 billion in biotech annual economic output and 369,000 directly and indirectly-created jobs in the state.  
January 31 2014
Dear Ms. Gibson: To Whom It May Concern: The Biotechnology Industry Organization (BIO) appreciates this opportunity to comment on the Texas Health and Human Services Commission (HHSC) proposed rule regarding 340B program reimbursement (the “Proposed Rule”).  BIO is the largest trade association to serve and represent the biotechnology industry in the United States and around the globe.  Indeed, BIO represents more than 1,000 biotechnology companies, academic institutions, state biotechnology centers, and related organizations.   BIO members are involved in the research and development of healthcare, agricultural, industrial, and environmental biotechnology products. 
May 8 2013
BIO  urges Florida Governor Scott to sign House Bill 365 – a bill related to the substitution of biologic and biosimilar medicines – which recently passed out of the Legislature.
February 1 2013
BIO supports passage of Florida House Bill 365, which provides requirements for pharmacist to dispense substitute biological products that are determined to be interchangeable for prescribed biological product.
July 11 2014
Today's oral arguments offered an important opportunity to educate stakeholders within Alameda County and all of California about the unnecessary and burdensome impacts that will result if this proposed take back program is allowed to stand.
June 25 2014
Transparent Communication Important for Patients and Physicians
May 29 2014
Delaware Governor Markell signed legislation designed to create a pathway for the substitution of interchangeable biologic medicines.
May 16 2014
BIO and Delaware Bio call upon Governor Markell to sign critical legislation to create a pathway for the substitution of interchangeable biologic medicines.
April 10 2014
BIO and Delaware Bio commend the Delaware State Senate for unanimously passing legislation yesterday designed to create a pathway for the substitution of interchangeable biologic medicines.